Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR092318A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 07-10-2015
Patent type: Formulations

Click within the document, or manually enter the page number below

CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)

Countries: Argentina Date: 2016
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)

Countries: Argentina Date: 2016
CILFA opposition, Navafenterol sacchrinate in combination with corticosteroids, (AR094910A1)

Countries: Argentina Date: 2016
CILFA opposition, bromhexine, (AR082381A1)

Countries: Argentina Date: 2013
CILFA opposition, 1 1 -beta-hydroxysteroid dehydrogenase 1 , (AR090999A1)

Countries: Argentina Date: 2015
CILFA opposition, metformin, simvastatin or atorvastatin,benazepril, lisinopril or losartan, aspirin, (AR091739A1)

Countries: Argentina Date: 2015
CILFA opposition, brigatinib, (AR111169A1)

Countries: Argentina Date: 2019
CILFA opposition, agomelatine, (AR095152A1)

Countries: Argentina Date: 2015
CILFA opposition, lactoferrin, (AR093894A1)

Countries: Argentina Date: 2015
CILFA opposition, montelukast and levocetirizine, (AR087177A1)

Countries: Argentina Date: 2015

Cilfa Opposition, Tobramycin, (Ar092318 A1)